サマリー

ベタメタゾンは、炎症を抑えるコルチコステロイドで、さまざまな皮膚疾患の治療に役立ちます。
市場分析と洞察。ベタメタゾン原薬の世界市場
COVID-19のパンデミックにより、Betamethasone APIの世界市場規模は2022年には百万米ドルと推定され、検討期間中のCAGRは%で2028年には百万米ドルに再調整されると予測されています。この健康危機による経済的変化を十分に考慮して、2021年のベタメタゾンAPIの世界市場では95%-99%が%を占めていますが、COVID-19後の期間では修正された%のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、注射分野は、この予測期間中、年率％で変化しています。
中国のBetamethasone APIの市場規模は2021年に百万米ドル、米国と欧州のBetamethasone APIはそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には％、中国と欧州はそれぞれ％と％で、中国の割合は2028年には％に達し、分析期間中のCAGRは％になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのベタメタゾンAPI市場では、ドイツが2028年までに100万米ドルに達すると予測されています（予測期間中のCAGRは%です）。
ベタメタゾンAPIの世界的な主要メーカーには、VTR Bio-Tech、Xianju Pharma、Tianyao、GlaxoSmithKline、Sanofi、Symbiotec Pharmalab、Xinhua Pharma、Xianju Junye Pharma、Avik Pharmaceuticalなどがあります。2021年には、世界のトップ5社の売上高シェアは約%となっています。
世界のベタメタゾンAPIのスコープとセグメント
ベタメタゾンAPI市場は、タイプ別、アプリケーション別に分類されています。世界のBetamethasone API市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
95%-99%
90%-95%
その他
アプリケーション別
注射
経口
その他
会社別
VTRバイオテック
Xianju Pharma
Tianyao
GlaxoSmithKline（グラクソ・スミスクライン
サノフィ
シンビオテック・ファーマラボ
新華製薬
Xianju Junye Pharma
アビックファーマ
Great Pacific Exports
太華製薬
テバ
Xianjuxianle Pharma
パシフィックファーマ
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Betamethasone API Product Introduction
1.2 Market by Type
1.2.1 Global Betamethasone API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 95%-99%
1.2.3 90%-95%
1.2.4 Others
1.3 Market by Application
1.3.1 Global Betamethasone API Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Injection
1.3.3 Oral
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Betamethasone API Sales Estimates and Forecasts 2017-2028
2.2 Global Betamethasone API Revenue Estimates and Forecasts 2017-2028
2.3 Global Betamethasone API Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Betamethasone API Sales by Region
2.4.1 Global Betamethasone API Sales by Region (2017-2022)
2.4.2 Global Sales Betamethasone API by Region (2023-2028)
2.5 Global Betamethasone API Revenue by Region
2.5.1 Global Betamethasone API Revenue by Region (2017-2022)
2.5.2 Global Betamethasone API Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Betamethasone API Sales by Manufacturers
3.1.1 Global Top Betamethasone API Manufacturers by Sales (2017-2022)
3.1.2 Global Betamethasone API Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Betamethasone API in 2021
3.2 Global Betamethasone API Revenue by Manufacturers
3.2.1 Global Betamethasone API Revenue by Manufacturers (2017-2022)
3.2.2 Global Betamethasone API Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Betamethasone API Revenue in 2021
3.3 Global Betamethasone API Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Betamethasone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Betamethasone API Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Betamethasone API Sales by Type
4.1.1 Global Betamethasone API Historical Sales by Type (2017-2022)
4.1.2 Global Betamethasone API Forecasted Sales by Type (2023-2028)
4.1.3 Global Betamethasone API Sales Market Share by Type (2017-2028)
4.2 Global Betamethasone API Revenue by Type
4.2.1 Global Betamethasone API Historical Revenue by Type (2017-2022)
4.2.2 Global Betamethasone API Forecasted Revenue by Type (2023-2028)
4.2.3 Global Betamethasone API Revenue Market Share by Type (2017-2028)
4.3 Global Betamethasone API Price by Type
4.3.1 Global Betamethasone API Price by Type (2017-2022)
4.3.2 Global Betamethasone API Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Betamethasone API Sales by Application
5.1.1 Global Betamethasone API Historical Sales by Application (2017-2022)
5.1.2 Global Betamethasone API Forecasted Sales by Application (2023-2028)
5.1.3 Global Betamethasone API Sales Market Share by Application (2017-2028)
5.2 Global Betamethasone API Revenue by Application
5.2.1 Global Betamethasone API Historical Revenue by Application (2017-2022)
5.2.2 Global Betamethasone API Forecasted Revenue by Application (2023-2028)
5.2.3 Global Betamethasone API Revenue Market Share by Application (2017-2028)
5.3 Global Betamethasone API Price by Application
5.3.1 Global Betamethasone API Price by Application (2017-2022)
5.3.2 Global Betamethasone API Price Forecast by Application (2023-2028)
6 North America
6.1 North America Betamethasone API Market Size by Type
6.1.1 North America Betamethasone API Sales by Type (2017-2028)
6.1.2 North America Betamethasone API Revenue by Type (2017-2028)
6.2 North America Betamethasone API Market Size by Application
6.2.1 North America Betamethasone API Sales by Application (2017-2028)
6.2.2 North America Betamethasone API Revenue by Application (2017-2028)
6.3 North America Betamethasone API Market Size by Country
6.3.1 North America Betamethasone API Sales by Country (2017-2028)
6.3.2 North America Betamethasone API Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Betamethasone API Market Size by Type
7.1.1 Europe Betamethasone API Sales by Type (2017-2028)
7.1.2 Europe Betamethasone API Revenue by Type (2017-2028)
7.2 Europe Betamethasone API Market Size by Application
7.2.1 Europe Betamethasone API Sales by Application (2017-2028)
7.2.2 Europe Betamethasone API Revenue by Application (2017-2028)
7.3 Europe Betamethasone API Market Size by Country
7.3.1 Europe Betamethasone API Sales by Country (2017-2028)
7.3.2 Europe Betamethasone API Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Betamethasone API Market Size by Type
8.1.1 Asia Pacific Betamethasone API Sales by Type (2017-2028)
8.1.2 Asia Pacific Betamethasone API Revenue by Type (2017-2028)
8.2 Asia Pacific Betamethasone API Market Size by Application
8.2.1 Asia Pacific Betamethasone API Sales by Application (2017-2028)
8.2.2 Asia Pacific Betamethasone API Revenue by Application (2017-2028)
8.3 Asia Pacific Betamethasone API Market Size by Region
8.3.1 Asia Pacific Betamethasone API Sales by Region (2017-2028)
8.3.2 Asia Pacific Betamethasone API Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Betamethasone API Market Size by Type
9.1.1 Latin America Betamethasone API Sales by Type (2017-2028)
9.1.2 Latin America Betamethasone API Revenue by Type (2017-2028)
9.2 Latin America Betamethasone API Market Size by Application
9.2.1 Latin America Betamethasone API Sales by Application (2017-2028)
9.2.2 Latin America Betamethasone API Revenue by Application (2017-2028)
9.3 Latin America Betamethasone API Market Size by Country
9.3.1 Latin America Betamethasone API Sales by Country (2017-2028)
9.3.2 Latin America Betamethasone API Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Betamethasone API Market Size by Type
10.1.1 Middle East and Africa Betamethasone API Sales by Type (2017-2028)
10.1.2 Middle East and Africa Betamethasone API Revenue by Type (2017-2028)
10.2 Middle East and Africa Betamethasone API Market Size by Application
10.2.1 Middle East and Africa Betamethasone API Sales by Application (2017-2028)
10.2.2 Middle East and Africa Betamethasone API Revenue by Application (2017-2028)
10.3 Middle East and Africa Betamethasone API Market Size by Country
10.3.1 Middle East and Africa Betamethasone API Sales by Country (2017-2028)
10.3.2 Middle East and Africa Betamethasone API Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 VTR Bio-Tech
11.1.1 VTR Bio-Tech Corporation Information
11.1.2 VTR Bio-Tech Overview
11.1.3 VTR Bio-Tech Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 VTR Bio-Tech Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 VTR Bio-Tech Recent Developments
11.2 Xianju Pharma
11.2.1 Xianju Pharma Corporation Information
11.2.2 Xianju Pharma Overview
11.2.3 Xianju Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Xianju Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Xianju Pharma Recent Developments
11.3 Tianyao
11.3.1 Tianyao Corporation Information
11.3.2 Tianyao Overview
11.3.3 Tianyao Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Tianyao Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Tianyao Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Symbiotec Pharmalab
11.6.1 Symbiotec Pharmalab Corporation Information
11.6.2 Symbiotec Pharmalab Overview
11.6.3 Symbiotec Pharmalab Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Symbiotec Pharmalab Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Symbiotec Pharmalab Recent Developments
11.7 Xinhua Pharma
11.7.1 Xinhua Pharma Corporation Information
11.7.2 Xinhua Pharma Overview
11.7.3 Xinhua Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Xinhua Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Xinhua Pharma Recent Developments
11.8 Xianju Junye Pharma
11.8.1 Xianju Junye Pharma Corporation Information
11.8.2 Xianju Junye Pharma Overview
11.8.3 Xianju Junye Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Xianju Junye Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Xianju Junye Pharma Recent Developments
11.9 Avik Pharmaceutical
11.9.1 Avik Pharmaceutical Corporation Information
11.9.2 Avik Pharmaceutical Overview
11.9.3 Avik Pharmaceutical Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Avik Pharmaceutical Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Avik Pharmaceutical Recent Developments
11.10 Great Pacific Exports
11.10.1 Great Pacific Exports Corporation Information
11.10.2 Great Pacific Exports Overview
11.10.3 Great Pacific Exports Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Great Pacific Exports Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Great Pacific Exports Recent Developments
11.11 Taihua Pharma
11.11.1 Taihua Pharma Corporation Information
11.11.2 Taihua Pharma Overview
11.11.3 Taihua Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Taihua Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Taihua Pharma Recent Developments
11.12 Teva
11.12.1 Teva Corporation Information
11.12.2 Teva Overview
11.12.3 Teva Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Teva Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Teva Recent Developments
11.13 Xianjuxianle Pharma
11.13.1 Xianjuxianle Pharma Corporation Information
11.13.2 Xianjuxianle Pharma Overview
11.13.3 Xianjuxianle Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Xianjuxianle Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Xianjuxianle Pharma Recent Developments
11.14 Pacific Pharma
11.14.1 Pacific Pharma Corporation Information
11.14.2 Pacific Pharma Overview
11.14.3 Pacific Pharma Betamethasone API Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pacific Pharma Betamethasone API Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pacific Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Betamethasone API Industry Chain Analysis
12.2 Betamethasone API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Betamethasone API Production Mode & Process
12.4 Betamethasone API Sales and Marketing
12.4.1 Betamethasone API Sales Channels
12.4.2 Betamethasone API Distributors
12.5 Betamethasone API Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Betamethasone API Industry Trends
13.2 Betamethasone API Market Drivers
13.3 Betamethasone API Market Challenges
13.4 Betamethasone API Market Restraints
14 Key Findings in The Global Betamethasone API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer